Strides Pharma Faces Sector Downturn Amid Mixed Stock Performance and Moving Averages

Strides Pharma Science has experienced a notable decline of 5.65% on April 4, 2025, amidst a broader downturn in the pharmaceuticals and drugs sector, which fell by 3.03%. The stock's performance today underperformed the sector by 3.09%, marking a trend reversal after four consecutive days of gains. During the trading session, Strides Pharma reached an intraday high of Rs 715, reflecting a 2.21% increase, but also dipped to a low of Rs 666, representing a 4.8% decrease.
In terms of moving averages, Strides Pharma's stock is currently above its 5-day, 20-day, 50-day, and 200-day moving averages, yet remains below the 100-day moving average. This mixed performance comes as the Sensex continues to decline, having fallen by 562.09 points to 75,598.00, trading below its 50-day moving average, which is also below the 200-day moving average.

Over the past year, Strides Pharma has shown a significant gain of 64.63%, contrasting with the Sensex's modest increase of 1.82%. However, year-to-date performance indicates a slight decline of 0.38% for Strides Pharma, compared to a 3.28% drop in the Sensex.